Influenza A virus H5N1 vaccine (Novavax)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza A virus H5N1 vaccine (Novavax)

Drug Alias NameH5N1 Virus-Like Particle (VLP) Influenza vaccine (recombinant) (Novavax)H5N1 Clade 2 VLP influenza virus vaccine (Novavax)Pandemic influenza vaccine (Novavax)

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovavax

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovavax

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A